-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 2, Kangenbei issued an announcement stating that Hangzhou Kangenbei, a wholly-owned subsidiary, received the "Drug Supplementary Application Approval Notice" approved and issued by the National Medical Products Administration.
Peripheral neuropathy refers to a type of disease caused by the structure and dysfunction of peripheral motor, sensory and autonomic nerves.
As of the disclosure date of this announcement, four manufacturers of methylcobalamin tablets that have passed the consistency evaluation of the State Food and Drug Administration include Hangzhou Kangenbei and other four companies
According to data from Mi Nei.
Up to now, Hangzhou Kang Enbei has invested about RMB 5.
According to relevant national policies, medicines that pass the consistency evaluation will receive greater support in areas such as medical insurance payment and procurement by medical institutions
